Literature DB >> 10476084

Severe neutropenia as an adverse effect of methimazole in the treatment of hyperthyroidism.

J A Ryan1.   

Abstract

Ms. K., a white, 47-year-old female with a history of hyperthyroidism had been treated with methimazole daily for a period of 9 years. She presented with a 2-day history of fever higher than 103 degrees F and cellulitis of the right arm after a scratch injury. White blood cell count (WBC) was noted at 0.4 x 10(3)/microL and neutrophils at 5.6%, indicating agranulocytosis. Methimazole was discontinued by the patient with the onset of symptoms. Appropriate intravenous antibiotic therapy and reverse isolation were provided in the acute-care setting, as well as administration of the granulocyte colony-stimulating factor (G-CSF) filgrastim. No recovery of the granulocyte count or improvement of clinical condition was noted until her sixth day of admission, at which time her WBC increased to 2.6 x 10(3)/microL. The administration of intravenous antifungals and antibiotics prevented overwhelming sepsis, while giving the G-CSF the opportunity to stimulate growth of granulocytes to finally fight the offending organisms and save this patient.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476084

Source DB:  PubMed          Journal:  Clin Excell Nurse Pract        ISSN: 1085-2360


  1 in total

1.  Patient knowledge of antithyroid drug-induced agranulocytosis.

Authors:  Jonah Robinson; Max Richardson; Janis Hickey; Andy James; Simon H Pearce; Steve G Ball; Richard Quinton; Margaret Morris; Margaret Miller; Petros Perros
Journal:  Eur Thyroid J       Date:  2014-10-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.